Skip to main content
Top
Published in: Lung 1/2008

01-02-2008

Quality of Life and Psychosocial Aspects of Cough

Authors: Kate Brignall, Bhagyashree Jayaraman, Surinder S. Birring

Published in: Lung | Special Issue 1/2008

Login to get access

Abstract

Chronic cough is a common condition that causes considerable physical and psychological morbidity. The physical symptoms of cough are readily apparent; however, the psychosocial symptoms are often overlooked. Appreciation of the impact of cough on health-related quality of life has led to the development of three validated, cough-specific, health-related quality-of-life questionnaires that assess cough severity: Leicester Cough Questionnaire (LCQ), Cough-specific Quality of Life Questionnaire (CQLQ), and Chronic Cough Impact Questionnaire (CCIQ). These tools capture additional information not measured with objective tools and can be used to assess therapy. They should be used in conjunction with other cough severity measures such as cough frequency monitors to obtain a more complete assessment of cough severity. Recent cough guidelines endorse the measurement of cough-specific quality of life and these questionnaires are ideal tools to facilitate this.
Literature
1.
go back to reference Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343PubMedCrossRef Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343PubMedCrossRef
2.
go back to reference Raj AA, Birring SS (2007) Clinical assessment of chronic cough severity. Pulm Pharmacol Ther 20:334–337PubMedCrossRef Raj AA, Birring SS (2007) Clinical assessment of chronic cough severity. Pulm Pharmacol Ther 20:334–337PubMedCrossRef
3.
go back to reference Irwin RS (2006) Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):232S–237SPubMedCrossRef Irwin RS (2006) Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):232S–237SPubMedCrossRef
4.
go back to reference Dicpinigaitis PV, Tso R, Banauch G (2006) Prevalence of depressive symptoms among patients with chronic cough. Chest 130:1839–1483PubMedCrossRef Dicpinigaitis PV, Tso R, Banauch G (2006) Prevalence of depressive symptoms among patients with chronic cough. Chest 130:1839–1483PubMedCrossRef
5.
go back to reference McGarvey LPA, Carton C, Gamble LA, Heaney LG, Shepherd R, Ennis M, Macmahon J (2006) Prevalence of psychomorbidity among patients with chronic cough. Cough 2:4PubMedCrossRef McGarvey LPA, Carton C, Gamble LA, Heaney LG, Shepherd R, Ennis M, Macmahon J (2006) Prevalence of psychomorbidity among patients with chronic cough. Cough 2:4PubMedCrossRef
6.
go back to reference Birring SS, Murphy AC, Scullion JE, Brightling CE, Browning M, Pavord ID (2004) Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study. Respir Med 98:242–246PubMedCrossRef Birring SS, Murphy AC, Scullion JE, Brightling CE, Browning M, Pavord ID (2004) Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study. Respir Med 98:242–246PubMedCrossRef
7.
go back to reference Birring SS, Brightling CE, Symon FA, Barlow SG, Wardlaw AJ, Pavord ID (2003) Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 58:1066–1070PubMedCrossRef Birring SS, Brightling CE, Symon FA, Barlow SG, Wardlaw AJ, Pavord ID (2003) Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 58:1066–1070PubMedCrossRef
8.
go back to reference Birring SS, Parker D, Brightling CE, Bradding P, Wardlaw AJ, Pavord ID (2004) Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med 169:15–19PubMedCrossRef Birring SS, Parker D, Brightling CE, Bradding P, Wardlaw AJ, Pavord ID (2004) Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med 169:15–19PubMedCrossRef
9.
go back to reference French CT, Irwin RS, Fletcher KE, Adams TM (2002) Evaluation of a cough-specific quality-of-life questionnaire. Chest 121(4):1123–1131PubMedCrossRef French CT, Irwin RS, Fletcher KE, Adams TM (2002) Evaluation of a cough-specific quality-of-life questionnaire. Chest 121(4):1123–1131PubMedCrossRef
10.
go back to reference Baiardini I, Braido F, Fassio O, Tarantini F, Pasquali M, Tarchino F, Berlendis A, Canonica GW (2005) A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy 60(4):482–488PubMedCrossRef Baiardini I, Braido F, Fassio O, Tarantini F, Pasquali M, Tarchino F, Berlendis A, Canonica GW (2005) A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy 60(4):482–488PubMedCrossRef
11.
go back to reference Huisman AH, Wu MZ, Uil SM, van den Berg JWK (2007) Reliability and validity of a Dutch version of the Leicester Cough Questionnaire. Cough 3:3PubMedCrossRef Huisman AH, Wu MZ, Uil SM, van den Berg JWK (2007) Reliability and validity of a Dutch version of the Leicester Cough Questionnaire. Cough 3:3PubMedCrossRef
12.
go back to reference Kalpaklioglu AF, Kara T, Kurtipek E, Kocyigit P, Ekici A, Ekici M (2005) Evaluation and impact of chronic cough: comparison of specific vs generic quality-of-life questionnaires. Ann Allergy Asthma Immunol 94(5):581–585PubMedCrossRef Kalpaklioglu AF, Kara T, Kurtipek E, Kocyigit P, Ekici A, Ekici M (2005) Evaluation and impact of chronic cough: comparison of specific vs generic quality-of-life questionnaires. Ann Allergy Asthma Immunol 94(5):581–585PubMedCrossRef
13.
go back to reference Raj AA, Pavord ID, Birring SS (2006) What is the minimal important difference of the Leicester Cough Questionnaire? Thorax 61:P109 Raj AA, Pavord ID, Birring SS (2006) What is the minimal important difference of the Leicester Cough Questionnaire? Thorax 61:P109
14.
go back to reference Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, Thompson R (2007) Opiate therapy in chronic cough. Am J Respir Crit Care Med 175(4):312–315PubMedCrossRef Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, Thompson R (2007) Opiate therapy in chronic cough. Am J Respir Crit Care Med 175(4):312–315PubMedCrossRef
15.
go back to reference Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ (2007) AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC Pulm Med 7:4PubMedCrossRef Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ (2007) AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC Pulm Med 7:4PubMedCrossRef
16.
go back to reference Wong WCW, Lee A, Lam AT, Li KT, Leung CYM, Leung PC, Wong ELY, Tang JL (2006) Effectiveness of a Chinese herbal medicine preparation in the treatment of cough in uncomplicated upper respiratory tract infection: a randomised double-blinded placebo-control trial. Cough 2:5PubMedCrossRef Wong WCW, Lee A, Lam AT, Li KT, Leung CYM, Leung PC, Wong ELY, Tang JL (2006) Effectiveness of a Chinese herbal medicine preparation in the treatment of cough in uncomplicated upper respiratory tract infection: a randomised double-blinded placebo-control trial. Cough 2:5PubMedCrossRef
17.
go back to reference French CT, Fletcher KE, Irwin RS (2004) Gender differences in health related quality of life in patients complaining of chronic cough. Chest 125:482–488PubMedCrossRef French CT, Fletcher KE, Irwin RS (2004) Gender differences in health related quality of life in patients complaining of chronic cough. Chest 125:482–488PubMedCrossRef
18.
go back to reference Prudon B, Birring SS, Vara DD, Hall AP, Thompson JP, Pavord ID (2005) Cough and glottic stop reflex sensitivity in health and disease. Chest 127:550–557PubMedCrossRef Prudon B, Birring SS, Vara DD, Hall AP, Thompson JP, Pavord ID (2005) Cough and glottic stop reflex sensitivity in health and disease. Chest 127:550–557PubMedCrossRef
19.
go back to reference Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID (2006) Cough frequency, cough sensitivity and quality of life in patients with chronic cough. Respir Med 100:1105–1109PubMedCrossRef Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID (2006) Cough frequency, cough sensitivity and quality of life in patients with chronic cough. Respir Med 100:1105–1109PubMedCrossRef
20.
go back to reference Birring SS, Ing AJ, Chan K, Cossa G, Matos S, Morgan MD, Pavord ID (2007) Obstructive sleep apnoea: a cause of chronic cough. Cough 3:7PubMedCrossRef Birring SS, Ing AJ, Chan K, Cossa G, Matos S, Morgan MD, Pavord ID (2007) Obstructive sleep apnoea: a cause of chronic cough. Cough 3:7PubMedCrossRef
21.
go back to reference Jeyakumar A, Brickman T, Haben M (2006) Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116:2108–2112PubMedCrossRef Jeyakumar A, Brickman T, Haben M (2006) Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116:2108–2112PubMedCrossRef
Metadata
Title
Quality of Life and Psychosocial Aspects of Cough
Authors
Kate Brignall
Bhagyashree Jayaraman
Surinder S. Birring
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Lung / Issue Special Issue 1/2008
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-007-9034-x

Other articles of this Special Issue 1/2008

Lung 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.